Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
126 hedge funds and large institutions have $324M invested in Ventyx Biosciences in 2024 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 33 increasing their positions, 39 reducing their positions, and 37 closing their positions.
191% more capital invested
Capital invested by funds: $112M → $324M (+$213M)
23.08% more ownership
Funds ownership: 76.5% → 99.58% (+23%)
19% more call options, than puts
Call options by funds: $1.27M | Put options by funds: $1.07M
16% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 37
4% more funds holding
Funds holding: 121 → 126 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$16.2M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$14.5M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$12.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.6M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$9.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$11.4M |
| 2 |
Millennium Management
New York
|
-$6.68M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$4.94M |
| 4 |
Two Sigma Investments
New York
|
-$4.76M |
| 5 |
Two Sigma Advisers
New York
|
-$4.67M |
VTYX Hedge Fund Activity: Q1 2024 in Review
126 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2024, worth a combined $324M — up 191% from $112M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new VTYX positions and 37 closed out — a net gain of 6 holders — while 33 added to existing stakes and 39 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $16.2M. The largest seller was Morgan Stanley, cutting an estimated $11.4M.
- 126 institutional investors held Ventyx Biosciences (VTYX) as of Q1 2024, up from 121 in Q4 2023.
- Funds reported $324M of Ventyx Biosciences stock for Q1 2024, up 191% quarter-over-quarter.
- 43 funds opened new Ventyx Biosciences positions in Q1 2024 and 37 closed out, a net change of +6 holders.
- The largest Ventyx Biosciences buyer in Q1 2024 was Deerfield Management, an estimated $16.2M added.
- The largest Ventyx Biosciences seller in Q1 2024 was Morgan Stanley, an estimated $11.4M sold.
Based on aggregated 13F filings for Q1 2024.